Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.15 - $1.48 $575,000 - $740,000
-500,000 Reduced 76.92%
150,000 $192,000
Q4 2023

Feb 14, 2024

BUY
$1.22 - $1.62 $221,706 - $294,397
181,727 Added 38.81%
650,000 $884,000
Q3 2023

Nov 14, 2023

BUY
$0.98 - $1.62 $458,907 - $758,602
468,273 New
468,273 $721,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0

About AVROBIO, Inc.


  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Vazirani Asset Management LLC Portfolio

Follow Vazirani Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vazirani Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vazirani Asset Management LLC with notifications on news.